The effect of a new potent antifibrinolytic agent, tranexamic acid.
D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004717:Endometrium / Q000187:drug effects; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000188:drug therapy*; D014592:Uterine Hemorrhage / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D000933:Antifibrinolytic Agents